José-María Moraleda

22PUBLICATIONS
135CO-AUTHORS
Infectious diseasesHaematologyHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|May 12, 2026
Phase IIB, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Intravenous Defibrotide for the Prevention and Treatment of Respiratory Distress and Cytokine Release Syndrome in COVID-19.

|Jul 29, 2025
Defibrotide for Protecting Against and Managing Endothelial Injury in Hematologic Malignancies and COVID-19.

Edward Richardson, Clifton C Mo, Eleonora Calabretta

|Apr 15, 2025
Dynamics of Mutant Hematopoietic Progenitor Cells Are Not Associated with Clinical Outcomes in Multiple Myeloma.

Camila Guerrero, Maria-Jose Larrayoz, Irache Erdozain

|Nov 27, 2024
Clinical impact of [18F]FDG-PET/CT in ARI0002h treatment, a CAR-T against BCMA for relapsed/refractory multiple myeloma.

Inés Zugasti, Marta Tormo-Ratera, Aina Oliver-Caldés

|Sep 18, 2024
Measurable residual disease by mass spectrometry and next-generation flow to assess treatment response in myeloma.

Noemí Puig, Cristina Agulló, Teresa Contreras

|Jul 27, 2024
Bioengineered Mesenchymal Stem/Stromal Cells in Anti-Cancer Therapy: Current Trends and Future Prospects.

Jesús I Gil-Chinchilla, Agustín G Zapata, Jose M Moraleda

Pageof 4

Frequent Collaborators

7 joint publications

Maria-Victoria Mateos

6 joint publications

Valentín Cabañas

5 joint publications

Laura Rosiñol

5 joint publications

David García-Bernal